{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T14:36:15Z","timestamp":1776004575951,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10096-016-2581-4","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T08:28:32Z","timestamp":1453883312000},"page":"625-631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides"],"prefix":"10.1007","volume":"35","author":[{"given":"A.","family":"Capone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cafiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Campanile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Petrosillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"2581_CR1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","volume":"54","author":"SJ Hal van","year":"2012","unstructured":"van Hal SJ, Lodise TP, Paterson DL (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54:755\u2013771","journal-title":"Clin Infect Dis"},{"key":"2581_CR2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jac\/dkq050","volume":"65","author":"YK Yoon","year":"2010","unstructured":"Yoon YK, Kim JY, Park DW et al (2010) Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 65:1015\u20131018","journal-title":"J Antimicrob Chemother"},{"key":"2581_CR3","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/jac\/dku135","volume":"69","author":"TP Lodise","year":"2014","unstructured":"Lodise TP, Drusano GL, Lazariu V et al (2014) Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin. J Antimicrob Chemother 69:2547\u20132545","journal-title":"J Antimicrob Chemother"},{"key":"2581_CR4","volume":"16","author":"NN Mishra","year":"2014","unstructured":"Mishra NN, Bayer AS, Weidenmaier C et al (2014) Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons. PLoS One 16, e107426","journal-title":"PLoS One"},{"key":"2581_CR5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.00918-10","volume":"55","author":"ML Schweizer","year":"2011","unstructured":"Schweizer ML, Furuno JP, Sakoulas G et al (2011) Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob Agents Chemother 55:1082\u20131087","journal-title":"Antimicrob Agents Chemother"},{"key":"2581_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1471-2334-11-287","volume":"11","author":"Y Harigaya","year":"2011","unstructured":"Harigaya Y, Ngo D, Lesse AJ et al (2011) Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of Staphyloccocus aureus. BMC Infect Dis 11:287","journal-title":"BMC Infect Dis"},{"key":"2581_CR7","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JCM.06307-11","volume":"50","author":"V Cafiso","year":"2012","unstructured":"Cafiso V, Bertuccio T, Spina D et al (2012) A novel \u03b4-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate S. aureus. J Clin Microbiol 50:1742\u20131744","journal-title":"J Clin Microbiol"},{"key":"2581_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.diagmicrobio.2014.12.006","volume":"81","author":"SC Chang","year":"2015","unstructured":"Chang SC, Liu TP, Chen CJ et al (2015) Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates using a combination of \u03b4-hemolysis assay and Etest. Diagn Microbiol Infect Dis 81:246\u2013250","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2581_CR9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2015.05.008","volume":"46","author":"S Stefani","year":"2015","unstructured":"Stefani S, Campanile F, Santagati M et al (2015) Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: a review of the available evidence. Int J Antimicrob Agents 46:278\u2013289. doi: 10.1016\/j.ijantimicag.2015.05.008","journal-title":"Int J Antimicrob Agents"},{"key":"2581_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","volume":"1277","author":"AS Bayer","year":"2013","unstructured":"Bayer AS, Schneider T, Sahl HG et al (2013) Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann N Y Acad Sci 1277:139\u2013158","journal-title":"Ann N Y Acad Sci"},{"key":"2581_CR11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2013.10.001","volume":"43","author":"V Cafiso","year":"2014","unstructured":"Cafiso V, Bertuccio T, Purrello S et al (2014) dltA overexpression: a strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 43:26\u201331","journal-title":"Int J Antimicrob Agents"},{"key":"2581_CR12","volume":"9","author":"NN Mishra","year":"2014","unstructured":"Mishra NN, Bayer AS, Weidenmaier C et al (2014) Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons. PLoS One 9, e107426","journal-title":"PLoS One"},{"key":"2581_CR13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkr066","volume":"66","author":"PG Kelley","year":"2011","unstructured":"Kelley PG, Gao W, Ward PB et al (2011) Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. J Antimicrob Chemother 66:1057\u20131060","journal-title":"J Antimicrob Chemother"},{"key":"2581_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029573","volume":"7","author":"V Cafiso","year":"2012","unstructured":"Cafiso V, Bertuccio T, Spina D et al (2012) Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains. PLoS One 7, e29573","journal-title":"PLoS One"},{"key":"2581_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-8-22","volume":"8","author":"F Campanile","year":"2009","unstructured":"Campanile F, Bongiorno D, Borbone S et al (2009) Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy. Ann Clin Microbiol Antimicrob 8:22","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2581_CR16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.diagmicrobio.2008.09.012","volume":"63","author":"S Stefani","year":"2009","unstructured":"Stefani S, Bongiorno D, Cafiso V et al (2009) Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus strain responsible for a case of severe pneumonia. Diagn Microbiol Infect Dis 63:100\u2013104","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2581_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1574-695X.2007.00298.x","volume":"51","author":"V Cafiso","year":"2007","unstructured":"Cafiso V, Bertuccio T, Santagati M et al (2007) agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus. FEMS Immunol Med Microbiol 51:220\u2013227","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2581_CR18","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30, e36","journal-title":"Nucleic Acids Res"},{"key":"2581_CR19","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/AAC.00398-11","volume":"55","author":"M Matsuo","year":"2011","unstructured":"Matsuo M, Hishinuma T, Katayama Y et al (2011) Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob Agents Chemother 55:4188\u20134195","journal-title":"Antimicrob Agents Chemother"},{"key":"2581_CR20","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/AAC.00437-10","volume":"54","author":"L Cui","year":"2010","unstructured":"Cui L, Isii T, Fukuda M et al (2010) An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob Agents Chemother 54:5222\u20135233","journal-title":"Antimicrob Agents Chemother"},{"key":"2581_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","volume":"9","author":"PA Moise","year":"2009","unstructured":"Moise PA, North D, Steenbergen JN et al (2009) Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 9:617\u2013624","journal-title":"Lancet Infect Dis"},{"key":"2581_CR22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00134-014-3571-6","volume":"41","author":"M Bassetti","year":"2015","unstructured":"Bassetti M, Villa G, Ansaldi F et al (2015) Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. Intensive Care Med 41:366\u2013368","journal-title":"Intensive Care Med"},{"key":"2581_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/47.2.153","volume":"47","author":"T Wichelhaus","year":"2001","unstructured":"Wichelhaus T, Sch\u00e4fer V, Brade V et al (2001) Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus. J Antimicrob Chemother 47:153\u2013156","journal-title":"J Antimicrob Chemother"},{"key":"2581_CR24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jac\/dkp287","volume":"64","author":"MV Smirnova","year":"2009","unstructured":"Smirnova MV, Vostrov SN, Strukova EV et al (2009) The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models. J Antimicrob Chemother 64:815\u2013820","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2581-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2581-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2581-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:35:19Z","timestamp":1559122519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2581-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2581"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2581-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}